Recent Updates
Recently added Catalysts
TECX Positive Sentiment

Tectonic Therapeutic to Participate in the Morgan Stanley Global Healthcare Conference

Key Takeaway: Tectonic Therapeutic, a clinical-stage biotechnology company, announced its participation in the Morgan Stanley 24th Annual Global Healthcare Conference. CEO Alise Reicin will engage in a fireside chat, which will be available live and for replay on the company's website. The management team will also hold one-on-one meetings with investors during the event.

Market Sentiment Analysis

POSITIVE FACTORS

  • Tectonic Therapeutic is actively engaging with investors.
  • Participation in a prestigious conference highlights company visibility.
  • Focus on GPCR-targeted drug discovery addresses significant medical needs.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+69%
120-day peak, hindsight
Typical move
6.1%
average across 3 past catalysts
Cash runway
~31 mo
Minimal dilution risk
Lead asset
TX000045- Dose A
Phase 2 · Pulmonary Hypertension

Full Press Release Details

WATERTOWN, Mass., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (“Tectonic”), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs), today announced that Alise Reicin, MD, President and Chief Executive Officer, will participate in a fireside chat at the upcoming Morgan Stanley 24th Annual Global Healthcare Conference.

Morgan Stanley 24th Annual Global Healthcare Conference

Date: September 14, 2026
Time: 5:35 PM ET
Location: New York, NY
Format: Fireside Chat
Presenter: Alise Reicin, MD, President and Chief Executive Officer
Webcast: Link
The live fireside chat can also be accessed under “ Events & Presentations ” on the Investors section of the Tectonic website at www.tectonictx.com. Once the live event has concluded, a replay of the event will be available on the Company’s website for approximately 90 days.
The Tectonic management team will host one-on-one meetings during the conference. Interested investors should contact their Morgan Stanley representative to schedule meetings.
About Tectonic Tectonic Therapeutic is a clinical-stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Leveraging its proprietary technology platform called GEODe™ (GPCRs Engineered for Optimal Discovery), Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery and harness the human body to modify the course of disease. Tectonic focuses on areas of significant unmet medical need, often where therapeutic options are poor or nonexistent, as these are areas where new medicines have the potential to improve patient quality of life. Tectonic is headquartered in Watertown, Massachusetts. For more information, please visit www.tectonictx.com and follow us on LinkedIn.

Frequently Asked Questions

Who is participating in the Morgan Stanley conference?

Alise Reicin, MD, President and CEO of Tectonic Therapeutic, will participate.

How can investors access the conference chat?

The live chat can be accessed on Tectonic's website under 'Events & Presentations'.

What is the focus of Tectonic Therapeutic?

Tectonic focuses on developing therapeutic proteins and antibodies for GPCRs.

Where is Tectonic Therapeutic located?

Tectonic Therapeutic is headquartered in Watertown, Massachusetts.

Last updated: Sep 3, 2026